Dear Colleagues,
Welcome to the December 2010 issue of Science Speaks!
In this month's issue of Science Speaks we are featuring emerging countries in Latin America. We have included two articles written by our life science expert on outsourcing clinical trials to Latin American countries dominant in clinical research i.e. Brazil and Mexico.
Take a look also at this month's Biotech News section on a new Spanish website in support of product commercialization adapted specifically for the Latin American market.
Please visit our website at www.languageconnections.com to learn more about our services and publications.
Enjoy!
|
Addressing Challenges in Brazilian Clinical Trials
|
 Did you know, according to EU MAA data, that clinical trials in Latin America recruited 91% more patients per site than studies conducted in the U.S. between 2005 and 2009 (Outsourcing Pharma.com)? Among emerging countries in Latin America, Brazil's has exhibited the most growth in clinical research activity in the region, positioning it as one of the top three emerging countries for Western companies outsourcing clinical trials. Addressing Challenges in Brazilian Clinical Trials |
Conducting Clinical Trials in Mexico
|
 Latin America is recently emerging as a market of choice for outsourcing clinical trials. Along with Argentina and Brazil, Mexico has become a prominent clinical trial location in the region. A number of factors have contributed to this, including successful patient recruitment of eligible individuals. However, foreign sponsors must be aware of several issues to better ensure their success in the country.
Read more...
|
| Biotech News: A New Spanish Website for Latin American Market |
 Latin American trials are exponentially increasing. As a result, Latin America has become an important emerging market for new biopharmaceutical products. This in turn has led to the need to translate more materials into Spanish and Brazilian Portuguese. One U.S.-based company, Radient Pharmaceuticals, recently launched a Spanish website in support of product commercialization adapted specifically for the Latin American market. |
